[DOI] [PMC free article] [PubMed] [Google Scholar] 353.Garfield A.S., Patterson C., Skora S., Gribble F.M., Reimann F., Evans M.L
A University of Oxford review published in The BMJ, analyzing 37 studies across 9,300 adults, found that most people who stop GLP-1 medications regain their lost weight within two years, often at a rate of 0.3 kg per month faster than those using traditional diet and exercise programs
The GLP-1 receptor agonist cardiovascular therapy market is expanding due in large part to the rising incidence of type 2 diabetes, obesity, and cardiovascular disease
A recent observational casecontrol study reported improvements in the quality of life, depressive complaints, and pain scores after 1 month of combined physical exercise and acetylcarnitine supplementation compared with physical exercise alone [115]